The current price of BIVI is $1.21 — it has decreased by 9.70% since the previous close. Data as of Nov 5, 2026.
BIVI is down 12.95% over the past week, down 15.97% over the past month and down 21.94% over the past year. The price is below its 200-day moving average of $1.52.
Of the 2 analysts covering BioVie Inc., 2 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
BioVie Inc. has a market capitalization of $10.51M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, BioVie Inc. posted a loss of $0.70 per share against an estimate of -$0.52, missing expectations by 34.62%. Upcoming reports are listed in the earnings calendar.
BioVie Inc. has not paid any dividends over the past year.
In the latest trading session BIVI moved between $1.12 and $1.30, a range of 14.88% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of BioVie Inc. shows a sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for BioVie Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks BIVI has traded between $0.82 and $3.79. The current price is 68.07% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.